Resurrect Bio expands Series A to $10.3m to scale tech helping plants to defend themselves

UK AgriBioTech startup Resurrect Bio closes €8.8 million Series A to develop disease-resistant crops

Resurrect Bio, a London-based agricultural BioTech startup developing disease-resistant crops, has closed its oversubscribed Series A funding round at €8.8 million ($10.3 million). In February 2026, the company made an initial close of over €6.8 million ($8 million) in its Series A round.  The round was led by Corteva through its Corteva Catalyst platform, with participation from Calculus Capital, Pymwymic, UKI2S (managed by Future Planet Capita…

Resurrect Bio expands Series A to $10.3m to scale tech helping plants to defend themselves

[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Resurrect Bio] UK-based Resurrect Bio—a startup equipping crops with genetic defenses against disease—has announced the final close of its Series A round at $10.3 million. This follows the $8.1 million initial close announced in February. The investment was led by Corteva through its Corteva Catalyst platform, with participation from Calculus Capital, Pymwymic, Future Planet Ca…